D2C Brand Be Clinical Bags ₹21 Cr To Double Down On Clinical Skincare

D2C skincare brand Be Clinical has secured an additional ₹21 Cr ($2.2 Mn) in its seed extension round, led by Sauce with participation from existing investor V3 Ventures and several angel investors. The funds will be used to bolster R&D efforts, expand its product line in skin, body, and haircare categories, increase manufacturing capacity, and enter new markets.

Be Clinical, founded by Hemangi Dhir in 2025, offers clinically tested products aimed at addressing ageing concerns among Indian consumers. The company claims a 1.2 lakh order count since launch and a high repeat purchase rate. Its product portfolio includes PlumpX Serum, FirmX Serum, Revive 10 Eye Cream, and Neck Repair Cream, available on its website and ecommerce platforms like Amazon and Flipkart.

Sauce's VP Zoeb Ali Khan highlighted the brand's full-stack approach, emphasizing its evidence-led model as a distinct advantage in the personal care sector. Be Clinical joins a growing list of Indian D2C beauty startups, including Dr Sheth’s, Pilgrim, Innovist, and Mamaearth, that are catering to the rising consumer demand for active ingredient-based skincare products with clinical validation.

The segment's growth is further fueled by increasing interest in India's $31.19 billion beauty and personal care market, projected to reach $48.72 billion by 2034, according to IMARC Group.